within Pharmacolibrary.Drugs.A_AlimentaryTractAndMetabolism.A02B_DrugsForPepticUlcerAndGastroOesophagealRefluxDiseaseGord.A02BX04_MethiosulfoniumChloride;

model MethiosulfoniumChloride
  extends Pharmacolibrary.Drugs.ATC.A.A02BX04;

  annotation (Documentation(
info       = "<html><body><table><tr><td>Drug:</td><td>A02BX04</td></tr><td>route:</td><td>oral</td></tr><tr><td>n-compartments</td><td>1</td></tr></table><p>Methiosulfonium chloride is a synthetic compound that was historically used for the treatment of peptic ulcer disease and gastric hyperacidity. It acts as a gastric acid suppressant, although its precise mechanism of action is not fully elucidated. The drug is largely obsolete and not in clinical use today; it is not found in current therapeutic guidelines, and its approval status has lapsed in most regions.</p><h4>Pharmacokinetics</h4><p>No published pharmacokinetic studies specifically reporting parameters for methiosulfonium chloride in humans or animals could be identified.</p><h4>References</h4><ol></ol></body></html>",
    revisions  = "<html><body><ul><li>06/2025 initial model generated by LLM gpt-4.1 from general data</li></ul></body></html>",
    experiment (StartTime = 0, StopTime = 86400, Tolerance = 1e-9, Interval = 1)
  ));
end MethiosulfoniumChloride;
